Summary
We report on the occurrence of CSF rhinorrhea in a group of 17 patients harbouring macroprolactinomas who were treated with a dopamine agonist (DA, bromocriptine) alone or the combination of DA and transcranial operation. In 2 out of 17 cases shrinkage of tumour remnants during therapy with the oral or injectable form of bromocriptine was responsible for delayed occurrence of rhinorrhea. Operative procedures for successfull closure of the fistulae were mandatory in both cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Afshar F, Thomas A (1982) Brimocriptine-induced cerebrospinal fluid rhinorrhea. Surg Neurol 18: 61–63
Aronoff SL, Daughaday WH, Laws ER (1979) Bromocriptine treatment of prolactinomas. N Engl J Med 300: 1391
Baskin DS, Wilson CB (1982) CSF rhinorrhea after bromocriptine for prolactinoma. N Engl J Med 306: 178
Brabant G, Brennecke I, Herrmann H, Friedrich H, Wagner TOF, vonzur Mühlen A, Hesch RD (1985) Hyperprolaktinämie und Prolaktinome. Dtsch med Wschr 110: 1564–1567
Cole IE, Keane M (1980) Cerebrospinal fluid rhinorrhea in pituitary tumours. JR Soc med 73: 244–254
Fagel WG, Hekster REM, Smith SJ, van der Viyver JCM (1986) Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma. Neuroradiology 28: 364–366
Holness RO, Shlossberg AH, Heffernan LPM (1984) Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma. Neurology 13: 111–113
Hubbard JL, Mc Donald TJ, Pearson BW, Laws ER (1985) Spontaneous cerebrospinal fluid rhinorrhea: evolving concepts in diagnosis and surgical management based on the Mayo Clinic experience from 1970–1981. Neurosurgery 16: 314–321
Lancranjan I, Montini M, Jaquet P, Hildebrandt G, Muhr C, Benker G (1987) Long-acting bromocriptine as initial treatment for prolactin-secreting macroadenomas. In: Ratnam SS, Teoh ES (eds) Advances in fertility and sterility series, Vol 5. The Parthenon Publishing Group, Carnforth Park Ridge
Landolt AM (1982) Cerebrospinal fluid rhinorrhea: a complication of therapy for invasive prolactinomas. Neurosurgery 11: 395–401
Liuzzi A, Dallabonzana D, Oppizzi G, Verde GG, Cozzi R, Chiodini P, Luccarelli G (1985) Low doses of dopamine agonists in the long-term treatment of macroprolactinomas. N Engl J Med 313: 656–659
Molitch HE, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO and the Bromocriptine Study Group (1985) Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 60: 698–705
Okuyama T, Sato O, Daibo M, Niwa J (1984) Cessation of cerebrospinal fluid rhinorrhea by bromocriptine treatment of a patient with invasive prolactinoma. No Shinkei Geka 12: 319–323
Stracke H, Schröder O, Bleyl H, Schatz H (1984) Assessment of definitive residual pituitary-adrenal function and of hydrocortisone replacement therapy 10 to 14 days after microsurgery for pituitary adenomas. Horm Metabol Res 16: 157–158
Vance ML, Evans EW, Throner MO (1984) Bromocriptine. Ann Intern Med 100: 78–91
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hildebrandt, G., Zierski, J., Christophis, P. et al. Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta neurochir 96, 107–113 (1989). https://doi.org/10.1007/BF01456167
Issue Date:
DOI: https://doi.org/10.1007/BF01456167